Looking Beyond Imatinib: Next Line of Targeted Drugs for CML Shows Promise
- 25 January 2006
- journal article
- other
- Published by American Medical Association (AMA) in JAMA
- Vol. 295 (4) , 369-370
- https://doi.org/10.1001/jama.295.4.369
Abstract
Atlanta—Promising results from a trial of imatinib for the treatment of chronic myeloid leukemia (CML) created a stir 6 years ago at the annual meeting of the AKeywords
This publication has 0 references indexed in Scilit: